Currently, HSIC's 12-month EPS stands at $3.33, according to the most recent financial reports. During 2025, HSIC reported a per-share earnings of $3.29, which shows a rise compared to the EPS of $3.07 recorded in 2024. HSIC recorded an EPS of $0.93 for the quarterly period ending on Mar 28, 2026.
In 2025, Henry Schein's earnings per share was $3.29, a rise of 7.2% from $3.07 in 2024. Over the quarter ending Mar 28, 2026, the earnings per share came in at $0.93, reflecting a 4.5% increase compared to the same quarter a year earlier. As of March 2026, the TTM EPS is $3.33. During 2024, the annual earnings per share was $3.07, representing a decrease of 3.5% compared to 2023.
Henry Schein has recorded a growth in earnings per share of 4.5% over the past 12 months (YoY, quarterly). During the past three years, HSIC had an average yearly EPS growth of -5.9%. Henry Schein had an average annual EPS growth of 3.1% in the last five years. Over the last decade, HSIC had an average annual earnings per share growth of 1.3%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| MCK Mckesson Corp | 19.83 | 49.1% | 15.2% | N/A |
| HSIC Henry Schein Inc | 24.07 | 7.2% | -5.9% | 3.1% |
| CAH Cardinal Health Inc | 34.57 | 86.2% | N/A | N/A |
| IDXX Idexx Laboratories Inc | 39.49 | 22.3% | 17.5% | 14.1% |
| WOOF Petco Health & Wellness Company Inc | 126.75 | 108.1% | -55.5% | N/A |
| ACH Accendra Health Inc. | N/A | -202.5% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.